Details of the Drug Combinations

General Information of This Drug (ID: DM7ZOAE)

Drug Name

GFT-505 DM7ZOAE

Synonyms

GFT-1007; PPAR activator (dyslipidemia/type 2 diabetes), Genfit

Indication

Disease Entry	ICD 11	Status	REF
Non-alcoholic steatohepatitis	DB92.1	Phase 3	[1]
Type-2 diabetes	5A11	Phase 2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
GFT-505 + Indomethacin	DCA1XJU	Indomethacin	Drug-drug Interaction	[3]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02704403) Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) (RESOLVE-IT). U.S. National Institutes of Health.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025107)
3	ClinicalTrials.gov (NCT03985969) Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin